Blockbuster sales of its obesity and diabetes drugs have prompted Eli Lilly to launch a multibillion-dollar expansion of its drug manufacturing plant near Indianapolis.
Eli Lilly Plans Indiana Factory Expansion for Sales of Blockbuster Obesity, Diabetes Drugs
Pharmaceutical Giant To Invest $9.3 Billion in Manufacturing Plant Near Indianapolis
By Andy Peters
CoStar News
May 24, 2024 | 5:38 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Lilly Research Labaratories
893 Delaware St, Indianapolis, IN
- Indiana Enterprise Center
1300 Patterson Dr, Bloomington, IN
- Companies
- Lilly
Manufacturing
- Fluor
Construction
- Jacobs
Professional, Scientific, and Technical Services
- Messer Construction Co.
Construction
- Indiana Economic Development Corporation
Public Administration
- Contacts
- David Ricks
Chairman, President and Chief Executive Officer, Lilly